Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Is beyfortus approved in the us?

See the DrugPatentWatch profile for beyfortus

Yes. Beyfortus (belantamab mafodotin) is FDA‑approved in the United States. It received accelerated approval in 2022 for the treatment of relapsed or refractory multiple myeloma in patients who have received at least four prior lines of therapy, including an immunomodulatory drug, a proteasome inhibitor, and an anti‑CD38 antibody. As of now, that is its sole approved indication in the U.S.



Other Questions About Beyfortus :

Can beyfortus prevent rsv in babies? How long does it take for beyfortus to be effective? Beyfortus ingredients? Beyfortus patent? Who is the parent company of beyfortus? Ingredients in beyfortus? Who owns beyfortus?